- - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

-

ISSN Print: 2374-4677

ISSN Online:

主页: https://www.nature.com/npjbcancer

分享:

Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer

AKT1low quiescent cancer cells in ductal carcinoma in situ of the breast

Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT–tamoxifen hybrid therapy

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol

Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation

ESR1 mutations in metastatic lobular breast cancer patients

NDRG4 promoter hypermethylation is a mechanistic biomarker associated with metastatic progression in breast cancer patients

Dual endothelin receptor inhibition enhances T-DM1 efficacy in brain metastases from HER2-positive breast cancer

pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation

Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas

Hypothesis: can the abscopal effect explain the impact of adjuvant radiotherapy on breast cancer mortality?

Breast cancer risk factors and mammographic density among high-risk women in urban China

Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women

Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer

TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer

Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers

Perspective: bidirectional exosomal transport between cancer stem cells and their fibroblast-rich microenvironment during metastasis formation

Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations

Surgical Standards for Management of the Axilla in Breast Cancer Clinical Trials with Pathological Complete Response Endpoint

Exploration of PET and MRI radiomic features for decoding breast cancer phenotypes and prognosis

NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer

Sentinel lymph node B cells can predict disease-free survival in breast cancer patients

Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype

Correlating nuclear morphometric patterns with estrogen receptor status in breast cancer pathologic specimens

Tracking plasma DNA mutation dynamics in estrogen receptor positive metastatic breast cancer with dPCR-SEQ

An assessment of prognostic immunity markers in breast cancer

mTORC1 is a key mediator of RON-dependent breast cancer metastasis with therapeutic potential

Molecular determinants of post-mastectomy breast cancer recurrence

E2112: randomized phase iii trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer

Characterization of bone only metastasis patients with respect to tumor subtypes

Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer

Cognitive function following breast cancer treatment and associations with concurrent symptoms

Is there a role for immunotherapy in HER2-positive breast cancer?

MiR-221/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines

Unraveling the clinicopathological features driving the emergence of ESR1 mutations in metastatic breast cancer

An assessment of neuronal calcium sensor-1 and response to neoadjuvant chemotherapy in breast cancer patients

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort

Change in longitudinal trends in sleep quality and duration following breast cancer diagnosis: results from the Women’s Health Initiative

A functional genomic screen in vivo identifies CEACAM5 as a clinically relevant driver of breast cancer metastasis

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy

Association of B7-H4, PD-L1, and tumor infiltrating lymphocytes with outcomes in breast cancer

21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer

Clinical relevance of the 21-gene Recurrence Score？ assay in treatment decisions for patients with node-positive breast cancer in the genomic era

Androgen receptor expression in normal breast tissue and subsequent breast cancer risk

Genomic and expression profiling reveal molecular heterogeneity of disseminated tumor cells in bone marrow of early breast cancer

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705